Work

Mepolizumab response in patients with COPD and an eosinophilic phenotype with/without chronic bronchitis (CB): A METREX/METREO post hoc analysis

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.pa4783

Authors: Claus Vogelmeier, Daiana Stolz, Nicolas Roche, Meredith C. Mc Cormack, Robert Chan, Stefanie Kolterer, Bhabita Mayer, Alberto Papi

Institutions: Philipps University of Marburg, Universitätsklinikum Gießen und Marburg, German Center for Lung Research, University of Freiburg, Université Paris Cité, Hôpital Cochin, Institut Cochin, Johns Hopkins University, GlaxoSmithKline (United Kingdom), GlaxoSmithKline (Germany), University of Ferrara

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404096738

Cites:

Cited by:

Related to: 10